system
inflamm
particip
atherosclerosi
evolut
earli
develop
endotheli
dysfunct
format
matur
atheromat
plaqu
ultim
endpoint
ruptur
thrombot
complic
plaqu
ruptur
format
occlus
thrombu
caus
acut
coronari
syndrom
ac
inflammatori
cell
involv
activ
neutrophil
frequent
found
plaqu
vulner
ruptur
neutrophil
activ
report
unstabl
angina
ua
acut
myocardi
infarct
ami
patient
stabl
angina
sa
activ
seem
preced
myocardi
injuri
patient
ami
therefor
biomark
neutrophil
activ
could
prognost
even
diagnost
import
recent
studi
shown
gelatinas
b
also
known
matrix
endopeptidas
capabl
degrad
extracellular
matrix
thought
associ
atherosclerosi
plaqu
ruptur
therefor
consid
import
mediat
vascular
remodel
plaqu
instabl
action
enhanc
b
neutrophil
gelatinaseassoci
lipocalin
ngal
also
known
kda
glycoprotein
found
granul
human
neutrophil
mani
divers
function
scaveng
bacteri
product
modul
inflamm
iron
traffick
apoptosi
format
complex
ngal
crucial
atherosclerot
plaqu
eros
thrombu
format
ngal
also
produc
kidney
tubular
cell
respons
variou
ischem
toxic
insult
propos
earli
biomark
diagnosi
acut
kidney
injuri
studi
hypothes
level
ngal
blood
may
reflect
extent
neutrophil
activ
variou
stage
ac
could
discrimin
variou
type
ac
ua
nstemi
stemi
stabl
unstabl
coronari
syndrom
one
hundr
seventi
consecut
patient
program
coronari
angiographi
invas
cardiolog
depart
kat
gener
hospit
athen
greec
recruit
studi
june
octob
studi
perform
accord
principl
declar
helsinki
approv
hospit
ethic
committe
written
inform
consent
obtain
particip
patient
thirti
patient
exclud
studi
exclus
criteria
includ
neg
coronari
angiographi
patient
typic
chest
pain
consid
angina
fals
posit
singl
photon
emiss
comput
tomographi
spect
surgeri
previou
six
month
liver
diseas
end
stage
renal
diseas
renal
cardiac
liver
transplant
neoplasia
infect
sinc
affect
serumng
level
patient
fulfil
studi
criteria
clinic
assess
final
diagnosi
divid
follow
group
sa
n
ua
n
nstemi
n
stemi
n
twenti
healthi
amateur
athlet
without
risk
factor
serv
control
group
figur
demograph
clinic
characterist
patient
control
shown
tabl
patient
upon
present
emerg
room
underw
initi
clinic
assess
includ
clinic
histori
physic
examin
ecg
continu
ecg
monitor
standard
blood
test
includ
white
blood
cell
polymorphonuclear
neutrophil
count
troponini
test
repeat
hour
long
clinic
indic
determin
final
diagnosi
patient
cardiologist
blind
ngal
result
review
patient
avail
record
includ
patient
histori
laboratori
result
radiolog
test
ecg
echocardiographi
coronari
angiographi
complet
hospit
stay
sa
group
consist
patient
angiograph
document
organ
coronari
stenosi
quantit
coronari
angiographi
major
arteri
chronic
symptom
angina
posit
spect
test
ua
diagnos
patient
typic
angina
rest
sudden
increas
episod
previous
stabl
angina
ami
diagnos
evid
myocardi
necrosi
clinic
set
consist
myocardi
ischemia
necrosi
diagnos
rise
andor
fall
pattern
troponini
least
one
valu
cutoff
valu
defin
percentil
normal
popul
assay
show
imprecis
troponini
assay
fulfil
imprecis
criteria
concentr
ngml
serum
sampl
collect
sa
patient
morn
coronari
angiographi
ac
patient
pci
perform
within
hour
admiss
blood
sampl
collect
admiss
healthi
subject
sampl
collect
morn
train
serum
sampl
kept
frozen
test
total
white
blood
cell
count
wbc
peripher
polymorphonuclear
neutrophil
count
pmn
assess
use
celldyn
sapphir
haematolog
analyz
abbott
chicago
il
usa
serum
creatinin
measur
modifi
jaff
method
architect
analyz
abbott
chicago
il
usa
highsensit
crp
hscrp
measur
turbidimetr
assay
analyz
troponini
measur
chemiluminesc
immunoassay
analyz
serumng
measur
elisa
bioporto
gentoft
denmark
perform
ncss
statist
program
normal
distribut
quantit
data
test
shapirowilk
test
normal
distribut
paramet
data
present
mean
standard
deviat
comparison
mean
among
patient
group
healthi
control
standard
oneway
anova
test
use
serumng
distribut
normal
nonparametr
test
use
test
kruskalw
test
multiplecomparison
procedur
dunn
method
comparison
group
friedman
test
wilcoxon
test
bonferroni
correct
comparison
within
group
correl
determin
use
spearman
rankcorrel
coeffici
chisquar
statist
use
categor
variabl
p
valu
less
twotail
consid
indic
statist
signific
data
report
median
interquartil
rang
receiveroper
characterist
roc
analysi
perform
calcul
area
curv
auc
defin
cutoff
point
cutoff
valu
chosen
costbenefit
analysi
differ
auc
investig
nonparametr
approach
delong
delong
clarkepearson
statist
perform
ncss
statist
power
analysi
softwar
ncss
inc
kaysvil
ut
usa
differ
observ
median
serumng
valu
among
patient
group
healthi
control
signific
p
anova
test
statist
analysi
use
multiplecomparison
group
reveal
median
serumng
level
ua
ngml
nstemi
ngml
stemi
ngml
patient
significantli
higher
patient
sa
ngml
healthi
control
ngml
tabl
figur
also
signific
differ
observ
healthi
control
sa
patient
ua
patient
patient
ami
nstemi
stemi
patient
stemi
higher
level
ngal
patient
nstemi
differ
nonsignific
tabl
median
plasma
level
hscrp
similar
patient
sa
mgdl
ua
mgdl
significantli
higher
level
control
group
mgdl
hscrp
level
significantli
increas
patient
nstemi
mgdl
stemi
mgdl
order
investig
relationship
serumng
hscrp
perform
regress
analysi
serumng
hscrp
figur
analysi
reveal
linear
posit
correl
hscrp
serum
ngal
spearman
rank
correl
coeffici
rho
p
differ
observ
among
four
patient
group
wbc
pmn
count
statist
signific
p
anovatest
posit
signific
correl
serumng
wbc
r
p
pmn
r
p
count
figur
multivari
regress
analysi
model
enter
independ
paramet
age
serum
creatinin
hscrp
pmn
count
identifi
hscrp
p
pmn
count
p
independ
predictor
serumng
level
roc
curv
gener
sensit
specif
respect
area
curv
serumng
hscrp
pmn
count
figur
diagnost
valu
serumng
discrimin
patient
ua
sa
high
auc
better
hscrp
auc
pmn
count
auc
use
cutoff
serumng
ngml
predict
ua
event
sensit
specif
respect
neg
predict
valu
cutoff
high
diagnost
valu
serumng
discrimin
ac
patient
patient
sa
high
auc
better
hscrp
auc
pmn
count
auc
use
cutoff
serumng
ngml
discrimin
ac
patient
stabl
patient
sensit
specif
respect
neg
predict
valu
cutoff
high
studi
demonstr
serum
level
ngal
higher
patient
cad
healthi
control
patient
among
ac
patient
level
gradual
elev
accord
sever
coronari
clinic
syndrom
ua
nstemi
stemi
also
serum
level
ngal
higher
patient
ac
patient
sa
could
use
high
neg
valu
discrimin
patient
stabl
unstabl
coronari
syndrom
relev
ngal
cardiovascular
diseas
cvd
remain
primarili
unknown
elev
plasma
ngal
level
associ
atherosclerosi
implic
predictor
cardiovascular
mortal
cerebrovascular
ischemia
possibl
activ
blood
leukocyt
although
recent
report
shown
ngal
present
atherosclerot
plaqu
human
abdomin
aortic
aneur
rais
possibl
express
ngal
induc
vascular
cell
atherogenesi
underli
mechan
induct
ngal
vascular
cell
remain
unknown
analysi
main
sourc
ngal
found
neutrophil
probabl
recruit
vascular
wall
platelet
activ
ngal
consid
protect
effect
enhanc
proteolyt
activ
could
consid
import
factor
indirectli
contribut
progress
aneur
well
involv
physiolog
patholog
remodel
vessel
wall
view
support
observ
similar
neutrophil
overexpress
found
atherosclerot
plaqu
particularli
intramur
haemorrhag
debri
central
necrosi
evid
support
clinic
observ
highcircul
leucocyt
particularli
neutrophil
count
independ
predictor
recurr
ischaem
attack
may
explain
presenc
necrot
core
unstabl
plaqu
proteolyt
activ
toward
atherosclerot
tissu
secondari
mobil
thromboembol
fragment
evid
deriv
experiment
studi
show
close
link
neutrophil
product
natur
histori
atherosclerosi
complic
gener
clinic
studi
investig
clinic
util
serumng
measur
two
recent
studi
found
serum
level
ngal
significantli
elev
patient
angiograph
confirm
cad
compar
normal
arteri
control
data
agre
report
sinc
found
level
serumng
significantli
higher
patient
clinic
syndrom
cad
healthi
control
reinforc
util
ngal
biomark
detect
extent
cad
express
ngal
vascular
cell
atherogenesi
also
explain
differ
patient
sa
control
subject
risk
factor
observ
studi
addit
induct
vessel
mechanist
injuri
previou
studi
suggest
ngal
strongli
upregul
atherosclerot
lesion
also
heart
ischem
injuri
possibl
ngal
produc
vascular
cell
could
also
secret
system
circul
inflamm
play
critic
role
develop
progress
atherosclerosi
also
pathogenesi
destabil
atherosclerot
plaqu
lead
ac
activ
degranul
polymorphonuclear
neutrophil
probabl
underestim
critic
compon
acut
coronari
inflamm
event
infiltr
macrophag
neutrophil
particip
transform
stabl
coronari
arteri
plaqu
unstabl
lesion
thin
fibrou
cap
repeatedli
report
thrombos
plaqu
dens
infiltr
neutrophil
macrophag
macrophag
neutrophil
type
leukocyt
produc
variou
proteolyt
enzym
facilit
ruptur
plaqu
thin
weaken
normal
thick
firm
cap
ngal
one
protein
produc
distress
kidney
also
activ
neutrophil
vascular
wall
cell
recent
studi
shown
neutrophil
main
sourc
ngal
blood
increas
serum
ngal
result
activ
neutrophil
may
reflect
acut
system
inflammatori
respons
event
stroke
renal
failur
infect
also
link
presenc
chronic
inflammatori
diseas
atherosclerosi
whose
acut
clinic
manifest
repres
acut
chronic
inflamm
besid
neutrophil
ngal
also
express
epitheli
cell
renal
tubular
cell
hepatocyt
inflamm
injuri
data
agre
studi
sinc
found
posit
correl
level
serumng
system
inflamm
express
serum
hscrp
level
neutrophil
count
also
serum
level
ngal
higher
patient
ac
sa
higher
level
serumng
observ
patient
ac
compar
sa
could
explain
fact
neutrophil
activ
present
patient
acut
coronari
event
also
result
far
patient
sa
ami
similar
find
recent
publish
studi
show
plasma
level
ngal
higher
patient
ami
compar
patient
stabl
cad
clinic
practic
level
serumng
high
neg
predict
valu
patient
ua
ac
respect
serumng
could
use
discrimin
patient
ac
especi
ua
sa
without
cad
give
possibl
exclud
patient
symptom
similar
angina
true
ac
far
gradual
increas
serumng
accord
serious
unstabl
coronari
clinic
syndrom
could
reflect
intens
inflammatori
reaction
express
increment
increas
hscrp
neutrophil
count
combin
serum
ngal
especi
serumng
hscrp
correl
linear
posit
conclus
studi
show
serum
level
ngal
increas
patient
cad
everi
coronari
clinic
syndrom
reflect
inflammatori
statu
popul
high
neg
predict
valu
could
use
marker
discrimin
sa
chest
pain
without
cad
ac
also
patient
ac
serum
level
ngal
reflect
inflammatori
statu
could
show
sever
coronari
clinic
syndrom
ua
nstemi
stemi
